Skip to Content

Scientific Publications & Presentations

13 result(s) for your search

IN VIVO   platform

Ex VIVO   platform

attr

publication

Nov 16, 2024

CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy

The New England Journal of Medicine

hae

presentation

Oct 24, 2024

Results from Phase 2 Study of NTLA-2002 for Hereditary Angioedema

Intellia Therapeutics Sponsored Event

hae

presentation

Oct 24, 2024

Results From a Phase 2, Randomized, Placebo-Controlled Trial of CRISPR-Based Therapy NTLA-2002 for Hereditary Angioedema

American College of Allergy, Asthma & Immunology 2024 Annual Scientific Meeting

hae

publication

Oct 24, 2024

CRISPR-Based Therapy for Hereditary Angioedema

New England Journal of Medicine

hae

presentation

Jun 3, 2024

NTLA-2002 Long-Term Phase 1 Data Update from the Ongoing Phase 1/2 Study

Intellia Therapeutics Sponsored Event

hae

publication

Jan 31, 2024

CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema

New England Journal of Medicine

attr

presentation

Nov 2, 2023

Enabling the Development of Serum [TTR] as a Biomarker for Treatment of ATTR Amyloidosis

4th International ATTR Amyloidosis Meeting for Patients and Doctors

hae

presentation

Jun 12, 2023

NTLA-2002 Interim Clinical Data Update from Ongoing First-in-Human Study

Intellia Therapeutics Sponsored Event